drugset

drugset / Trial / NCT01168596

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

NCT01168596 ↗

Phase 4 Completed 30 enrolled University of Florida

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the research study is to determine if rasagiline is an effective treatment for fatigue in patients with Parkinson's disease (PD).

Timeline

Start: 2009-12
Primary completion: 2012-05
Completion: 2012-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Rasagiline	Small molecule	1 mg	—

Indications